Pramina Kumari Pandey
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Research Subjects
Pramina Kumari Pandey has a total of 33 co-authors. Here are the top co-authors by number of shared publications:
- Abhijit Mishra
Department of Materials Engineering, Indian Institute of Technology Gandhinagar, Palaj, Gandhinagar, 382355, India
3 shared publications Abhay Raj Singh Gautam
Indian Inst Technol, Mat Engn, Gandhinagar 382055, Gujarat, India
1 shared publicationAbhijit Mishra
Indian Inst Technol, Mat Engn, Gandhinagar 382055, Gujarat, India
1 shared publicationAbhimanyu Patharkar
National Institute of Pharmaceutical Education and Research (NIPER)—Ahmedabad, Gandhinagar, India
1 shared publicationAdit Rambhia
Department of Materials Engineering
1 shared publication- Bharti Malvi
National Institute of Technology, Jamshedpur, India
1 shared publication
Latest Publications
- Open Access
- 23 July 2025
- Published by American Chemical Society (ACS) in ACS Omega
- Vol. 10 (30) , 33814-33822
Antibacterial Activity of Cellulose Acetate–Graphene Oxide Composites: A Comprehensive Multimethod Assessment
Bacterial contamination remains a critical concern in the environmental and biomedical fields, driving the demand for multifunctional materials with reliable antibacterial properties. Cellulose acetate–graphene oxide (CA–GO) composites, as a class of polymer nanocomposites, offer an effective solution by combining the biocompatibility of cellulose acetate with the antimicrobial activity of graphene oxide. In this study, the antibacterial performance of CA–GO composites was systematically evaluated by using multiple analytical techniques to better understand their efficacy under diverse conditions. A suite of complementary methods, including the Contact Film Diffusion Assay, Surface Drop Viability Assay, and Dynamic Immersion Exposure Test, was employed to assess how variables such as GO concentration, bacterial strain type, and exposure settings influence antibacterial activity. Results showed that CA–GO composites exhibit strong antibacterial effects, particularly against Gram-positive bacteria, largely attributed to GO’s ability to disrupt bacterial membrane integrity through oxidative stress and physical interactions. This multimethod investigation highlights the importance of testing under varied conditions to capture the full spectrum of antibacterial behavior. The findings not only demonstrate the high potential of CA–GO composites for antimicrobial applications but also underscore the need for standardized evaluation protocols tailored to graphene-based polymer nanocomposites.
- 23 July 2025
- Published by American Chemical Society (ACS) in ACS Omega
- Vol. 10 (30) , 33814-33822
Open AccessAntibacterial Activity of Cellulose Acetate–Graphene Oxide Composites: A Comprehensive Multimethod Assessment
Bacterial contamination remains a critical concern in the environmental and biomedical fields, driving the demand for multifunctional materials with reliable antibacterial properties. Cellulose acetate–graphene oxide (CA–GO) composites, as a class of polymer nanocomposites, offer an effective solution by combining the biocompatibility of cellulose acetate with the antimicrobial activity of graphene oxide. In this study, the antibacterial performance of CA–GO composites was systematically evaluated by using multiple analytical techniques to better understand their efficacy under diverse conditions. A suite of complementary methods, including the Contact Film Diffusion Assay, Surface Drop Viability Assay, and Dynamic Immersion Exposure Test, was employed to assess how variables such as GO concentration, bacterial strain type, and exposure settings influence antibacterial activity. Results showed that CA–GO composites exhibit strong antibacterial effects, particularly against Gram-positive bacteria, largely attributed to GO’s ability to disrupt bacterial membrane integrity through oxidative stress and physical interactions. This multimethod investigation highlights the importance of testing under varied conditions to capture the full spectrum of antibacterial behavior. The findings not only demonstrate the high potential of CA–GO composites for antimicrobial applications but also underscore the need for standardized evaluation protocols tailored to graphene-based polymer nanocomposites.
- 24 December 2024
- Published by American Chemical Society (ACS) in ACS Applied Materials & Interfaces
- Vol. 17 (1) , 663-674
In Vitro and In-Silico Assessment of Gaussian Curvature-driven Internalization Kinetics of Nanoparticles
Nanoparticles have been of significant interest in various biomedical domains such as drug delivery, gene delivery, cytotoxicity analysis, and imaging. Despite the synthesis of a variety of nanoparticles, their cellular uptake efficiency remains a substantial obstacle, with only a small fraction of delivered nanoparticles (NPs) have been reported to traverse the cell membrane within 24 h. Consequently, higher doses are often necessitated, leading to increased toxicity concerns. In this investigation, we illustrate that nanoparticles having negative Gaussian curvature demonstrate rapid and efficient internalization into cells by lowering the energy barrier for membrane bending. Specifically, three types of gold nanoparticles; gold nanorods (GNR), gold nanodogbones at pH 4 (GDB4), and gold nanodogbones at pH 6 (GDB6) were synthesized, with Gaussian curvatures of 0, -166.91, and -376.62, respectively. Cellular uptake studies conducted via ICP-OES analysis reveal that GDB6 is taken up 140% more in A549 cells and 77% more in NIH3T3 cells compared to GNR. Confocal microscopy-based uptake studies further confirm the higher uptake of GDB6 compared to GNR. Additionally, molecular simulations indicate that GDB nanoparticles exhibit a significantly larger free energy change during translocation compared to GNR, emphasizing the impact of nanoparticle shape on uptake and translocation through the membrane and validating the efficacy of negative Gaussian curvature in enhancing cellular uptake, consistent with experimental observations. Overall, our findings emphasize the importance of nanoparticle curvature modulation in maximizing cellular uptake efficiency for improved biomedical applications, providing valuable insights into the design of nanomaterials for drug delivery purposes.
- 24 December 2024
- Published by American Chemical Society (ACS) in ACS Applied Materials & Interfaces
- Vol. 17 (1) , 663-674
In Vitro and In-Silico Assessment of Gaussian Curvature-driven Internalization Kinetics of Nanoparticles
Nanoparticles have been of significant interest in various biomedical domains such as drug delivery, gene delivery, cytotoxicity analysis, and imaging. Despite the synthesis of a variety of nanoparticles, their cellular uptake efficiency remains a substantial obstacle, with only a small fraction of delivered nanoparticles (NPs) have been reported to traverse the cell membrane within 24 h. Consequently, higher doses are often necessitated, leading to increased toxicity concerns. In this investigation, we illustrate that nanoparticles having negative Gaussian curvature demonstrate rapid and efficient internalization into cells by lowering the energy barrier for membrane bending. Specifically, three types of gold nanoparticles; gold nanorods (GNR), gold nanodogbones at pH 4 (GDB4), and gold nanodogbones at pH 6 (GDB6) were synthesized, with Gaussian curvatures of 0, -166.91, and -376.62, respectively. Cellular uptake studies conducted via ICP-OES analysis reveal that GDB6 is taken up 140% more in A549 cells and 77% more in NIH3T3 cells compared to GNR. Confocal microscopy-based uptake studies further confirm the higher uptake of GDB6 compared to GNR. Additionally, molecular simulations indicate that GDB nanoparticles exhibit a significantly larger free energy change during translocation compared to GNR, emphasizing the impact of nanoparticle shape on uptake and translocation through the membrane and validating the efficacy of negative Gaussian curvature in enhancing cellular uptake, consistent with experimental observations. Overall, our findings emphasize the importance of nanoparticle curvature modulation in maximizing cellular uptake efficiency for improved biomedical applications, providing valuable insights into the design of nanomaterials for drug delivery purposes.
- Open Access
- 22 November 2024
- Published by Elsevier in Journal of Materials Research and Technology
- Vol. 33, 8644-8654
Antimicrobial and antiviral properties of stainless steel enhanced by controlled silver nano-island deposition: A safe and sustainable by design approach
- 22 November 2024
- Published by Elsevier in Journal of Materials Research and Technology
- Vol. 33, 8644-8654
Open AccessAntimicrobial and antiviral properties of stainless steel enhanced by controlled silver nano-island deposition: A safe and sustainable by design approach
- Open Access
- 7 November 2024
- Published by American Chemical Society (ACS) in ACS Omega
- Vol. 9 (46) , 46204-46216
Coassembly of Cell-Penetrating Peptide Octaarginine with Acetazolamide: Emergent Interactions with E. coli
The investigation of established pharmaceutical agents for recalibrating usage strongly supplements new drug development. In this work, we have prepared coassembled complexes of acetazolamide (AZM) with the cationic peptide octaarginine (R8) in an attempt to enhance its potency and scope of use. R8 and AZM in different weight ratios coassemble into remarkable nano- and microstructures such as ribbons, sheets, and stick-like structures. A combination of FTIR, XRD, SEM, and DSC has been used to characterize the R8:AZM coassemblies. The sulfonamide SO2 and NH2 groups of AZM are associated with the guanidinium amine, free amine, and terminal carbonyl groups of R8 resulting in distinctive topologies. Treatment of Escherichia coli with the complexes results in a distinctive pattern of membrane disruption and pore formation. The R8:AZM coassemblies inhibit carbonic anhydrase and E. coli growth with greater efficiency compared to bare AZM. The 1:5 w/w complex leads to pronounced outer and inner membrane rupture and significantly restricts glucose uptake by E. coli. The ability of R8 and AZM to coassemble into a distinctive set of structures based solely on differences in their relative proportions and their engagement with E. coli as more than the sum of their parts are novel facets of R8 and AZM behavior and underscore a straightforward and elegant approach for enhancing the scope of use of small molecule drugs.
- 7 November 2024
- Published by American Chemical Society (ACS) in ACS Omega
- Vol. 9 (46) , 46204-46216
Open AccessCoassembly of Cell-Penetrating Peptide Octaarginine with Acetazolamide: Emergent Interactions with E. coli
The investigation of established pharmaceutical agents for recalibrating usage strongly supplements new drug development. In this work, we have prepared coassembled complexes of acetazolamide (AZM) with the cationic peptide octaarginine (R8) in an attempt to enhance its potency and scope of use. R8 and AZM in different weight ratios coassemble into remarkable nano- and microstructures such as ribbons, sheets, and stick-like structures. A combination of FTIR, XRD, SEM, and DSC has been used to characterize the R8:AZM coassemblies. The sulfonamide SO2 and NH2 groups of AZM are associated with the guanidinium amine, free amine, and terminal carbonyl groups of R8 resulting in distinctive topologies. Treatment of Escherichia coli with the complexes results in a distinctive pattern of membrane disruption and pore formation. The R8:AZM coassemblies inhibit carbonic anhydrase and E. coli growth with greater efficiency compared to bare AZM. The 1:5 w/w complex leads to pronounced outer and inner membrane rupture and significantly restricts glucose uptake by E. coli. The ability of R8 and AZM to coassemble into a distinctive set of structures based solely on differences in their relative proportions and their engagement with E. coli as more than the sum of their parts are novel facets of R8 and AZM behavior and underscore a straightforward and elegant approach for enhancing the scope of use of small molecule drugs.
- 7 June 2019
- Published by Elsevier
- p. 415-458
Hyaluronic Acid as an Emerging Technology Platform for Silencing RNA Delivery
- 7 June 2019
- Published by Elsevier
- p. 415-458
Hyaluronic Acid as an Emerging Technology Platform for Silencing RNA Delivery